Results 271 to 280 of about 2,936,501 (309)
Some of the next articles are maybe not open access.

Cell-Free Biosystems for Biomanufacturing

2012
Although cell-free biosystems have been used as a tool for investigating fundamental aspects of biological systems for more than 100 years, they are becoming an emerging biomanufacturing platform in the production of low-value biocommodities (e.g., H(2), ethanol, and isobutanol), fine chemicals, and high-value protein and carbohydrate drugs and their ...
Chun, You, Y-H Percival, Zhang
openaire   +2 more sources

Possible cell-free prion replication

Medical Hypotheses, 1992
Spongiform encephalopathies, such as scrapie or bovine spongiform encephalopathy in animals, or kuru, Creutzfeld-Jakob disease (CJD) and Gerstmann-Sträussler-Scheinker disease (GSS) in man, seem to be caused by a transmissible agent whose nature is still a matter of debate.
openaire   +2 more sources

Cell-Free DNA

Obstetrics and Gynecology Clinics of North America, 2018
Kristin D. Gerson, Barbara M. O’Brien
openaire   +1 more source

Logic invades cell-free biosensing

Nature Chemical Biology, 2022
Evan Amalfitano, Keith Pardee
openaire   +2 more sources

Cell-free DNA

Clinics in Laboratory Medicine, 2016
Pe’er Dar, Hagit Shani, Mark I. Evans
openaire   +1 more source

Cell-Free DNA Integrity: Applications

2018
Cell-free DNA integrity (cfDNAi) could be a valuable biomarker for solid tumors, to define prognosis and response to therapy. Several elements have been studied for cfDNAi, such as specific genes involved in cancer progression or repetitive DNA sequences as surrogate markers for the whole circulating DNA.However, the lack of a standardized method for ...
openaire   +2 more sources

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov   +2 more
exaly  

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Carl M Gay   +2 more
exaly  

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Home - About - Disclaimer - Privacy